WEIFANG, SHANDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- Introduction: A Global Innovator from Shandong, China ...

WEIFANG, SHANDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- 1. Rising Global Demand for PDT LED Light Therapy As ...

Investigators reported results from the first randomized controlled trial of office-based laser photocoagulation to standard TURBT for low-grade Ta bladder tumors.

Scientists all over the world are trying to develop treatments for various types of cancer, ideally without side effects. An international team that includes researchers from the Slovak Academy of ...

Phase 1 maximal-use pharmacokinetics (PK) study completed in support of planned U.S. label expansionData to complement previously announced ...

GA, UNITED STATES, February 4, 2026 / EINPresswire.com / — Researchers have developed a new biomimetic nanocomposite ...

HENDERSON, NV, UNITED STATES, February 4, 2026 /EINPresswire.com/ -- Promo Direct has introduced a new product category ...

The agreements, which extend through September 2029, provide a solid foundation for continued operational excellence while ensuring competitive wages and comprehensive benefits. By working together, ...

Phase 3 clinical trial results demonstrate that Ameluz photodynamic therapy is an effective treatment for actinic keratoses ...

US FDA acknowledges no filing deficiencies in Biofrontera’s sNDA for Ameluz PDT in superficial basal cell carcinoma: Woburn, Massachusetts Saturday, February 14, 2026, 16:00 Hrs ...

The FDA has accepted a sNDA for Ameluz topical gel, used in combination with the RhodoLED red-light lamp series, for superficial basal cell carcinoma treatment.

The FDA accepted the supplemental new drug application (sNDA) for aminolevulinic acid hydrochloride 10% topical gel (Ameluz) as part of photodynamic therapy (PDT) for superficial basal cell carcinoma ...